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Abstract: In elite sporting codes, the identification and promotion of future athletes into specialised
talent pathways is heavily reliant upon objective physical, technical, and tactical characteristics,
in addition to subjective coach assessments. Despite the availability of a plethora of assessments,
the dependence on subjective forms of identification remain commonplace in most sporting codes.
More recently, genetic markers, including several single nucleotide polymorphisms (SNPs), have been
correlated with enhanced aerobic capacity, strength, and an overall increase in athletic ability.
In this review, we discuss the effects of a number of candidate genes on athletic performance,
across single-skilled and multifaceted sporting codes, and propose additional markers for the
identification of motor skill acquisition and learning. While displaying some inconsistencies,
both the ACE and ACTN3 polymorphisms appear to be more prevalent in strength and endurance
sporting teams, and have been found to correlate to physical assessments. More recently,
a number of polymorphisms reportedly correlating to athlete performance have gained attention,
however inconsistent research design and varying sports make it difficult to ascertain the relevance to
the wider sporting population. In elucidating the role of genetic markers in athleticism, existing talent
identification protocols may significantly improve—and ultimately enable—targeted resourcing in
junior talent pathways.
Keywords: performance; ACE; ACTN3; talent identification; genetic polymorphism
1. Introduction
It is commonly discussed in the talent identification (TID) circles whether sporting talent is
“born or bred”. In a sporting context, there is a limit to the improvement an athletes’ performance can
make from practice alone; inferring that ability and skill are, at least, partially inherited qualities [1].
Short of there being a single gene responsible for sporting success, it is estimated that the human
genome has 10 million different single nucleotide polymorphisms (SNPs), with dozens currently linked
to sporting performance and sporting success across various sporting codes [2].
The ability to maximise athlete performance and athlete potential in elite environments is
constantly at the forefront of sport science. New technology and training methods are continually
being tested and developed to enhance performance and elevate athletes to an elite level status.
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When considering athletic performance, numerous generic and sport-specific assessments are
performed to identify sporting talent and to provide an indication of current athletic ability. The notable
increased inclusion of skill assessments in current athletic screening and testing batteries allows the
quantification of technical and tactical attributes of an athlete to determine how one may perform in
competition. Specifically, the utilisation of sport-specific skill assessments, including match day
statistics, are commonly used for determining player performance in Australian Football (AF),
basketball, soccer, and rugby union [3–10]. These assessments allow for an evaluation on player
skill performance and match day impact.
Currently, there are several methods of determining individual player achievement within a sport:
team selection, career success, coach perception, and match performance within a season [11,12]. In the
context of AF, athletic field tests—such as the vertical jump, 20-metre sprint, and endurance time
trials—are often used in the talent identification process to acknowledge athletes with the potential to
succeed in a given sport [13]. These tests reveal indications of physical capabilities that may enhance
or hinder an athlete’s ability to perform within a given sport or position within a sport. Similarly,
skill-based assessments have been introduced as an additional element, as a method to rank athletes on
their technical abilities [14]. As these tests are often performed within a testing battery during events
such as draft combines, the results from these tests give information on the skill level of an athlete, and
therefore an indication of the individual work required to elevate their abilities to an elite level.
Common genetic polymorphisms (natural variations in genetic sequences) account for the
variability in the expression of several key genes important in the regulation of physiological
processes. Among these, single nucleotide polymorphisms (SNPs) have gained significant attention
as contributors of behavioural, physiological, and cognitive variability [15]. Owing to the diverse
array of desirable physical attributes in sport, several polymorphisms within the human genome
have previously been highlighted. For example, the angiotensin-converting enzyme (ACE) and
alpha-actinin-3 (ACTN3) genes have both been linked with elite levels of athletic performance in
endurance and/or strength/power dominant sports; including long distance running and swimming,
road cycling, rowing, cross-country skiing, triathlons, sprinting, volleyball, track and field jumping
and throwing, weightlifting, ice hockey, wrestling, and figure skating [16–20]. In addition, specific
homozygous genotypes in the peroxisome proliferator-activated receptor gamma co-activator 1-alpha
(PPARGC1A) gene and the beta-adrenergic receptors 1/2/3 (ADRB 1/2/3) have been linked with higher
maximal oxygen uptake (VO2max), better endurance performance and more favourable body mass
index in long-distance runners, long-distance swimmers road cyclists, cross-country skiers, triathletes,
sprinters, sprint swimmers, weight and power lifters, track and field jumpers and throwers, boxers,
and kayakers [21–23].
Despite the intriguing nature of these studies, there has been no strong candidate genes associated
with performance in skill execution within sport. Polymorphisms within the brain-derived neurotropic
factor (BDNF), dopamine D2 receptor (DRD2), and catechol-O-methyltransferase (COMT) genes have
all been associated with motor control and/or learning [24,25]. However, none of these genes have
previously been investigated in the context of sport-specific skill analysis. In AF, using standard
skill performance assessments, a relationship between player genotype and performance has been
identified [5]. However, the genetic implication of these tests has only been previously investigated
once, in a small cohort of sub-elite AF players, while match performance has not been investigated in a
genetic capacity at all.
2. Talent Detection and Identification
All traditional athlete development pathways share a common goal, to identify and develop
individuals with the greatest long-term potential for success in elite competition [13]. The common
development process of many sporting codes reflects the model proposed by Williams and Reilly [26],
which involves the process of athlete detection, identification, selection, and development. In this
model, athletes are selected to participate in development programs based on detection (the process
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of unearthing potential elite performers not currently participating in the sport in question) or
identification (recognising those currently in the pathway with the potential to excel) outcomes.
Athlete detection and identification is critical to the athlete development process, as they typically
guide the initial, and subsequent, selection of athletes into development programs.
Assessments utilised in the identification and detection process are typically considered sport
specific. For example, the testing battery used at national draft combines of the Australian Football
League (AFL), National Football League (NFL), and National Basketball Association (NBA) may
be considered highly specific to each of the particular sports. Each sport adopts performance tests
that are considered to best represent the physical demands of that particular sport [13]. Due to the
multi-disciplinary nature of most team sports, testing often examines a range of physical performance
measures—such as aerobic capacity, anaerobic power, and technical skill—with results used to guide
higher or elite level selection [27–29]. However, while there are test that are specific to each sport,
usually skill specific, these tests are performed in closed-environment settings and do not have the
ability to assessment an athlete’s decision making skills or execute skill under pressure. The lack of
testing in open-environment is a flaw in current TID testing batteries.
3. Measurements of Sporting Performance
Prior to discussing gene candidates and their potential relation to athlete performance, skill
performance, and match performance, it is first important to identify and describe the current
assessments commonly utilised to measure these athletic performance domains, and so too the qualities
they measure.
3.1. Measurements of Athletic Performance
3.1.1. Aerobic Assessment
An athlete’s ability to recover between bouts of high intensity effort is linked to their aerobic
capacity [30,31]. Aerobic capacity is most accurately assessed as a measure of maximal oxygen uptake
(VO2max) [32,33], however true VO2max testing in team sport environments is uncommon due to
specialist equipment requirements and cost. Due to these limitations, predicted VO2max measures
are more commonly used. Many indirect measures exist, with most assessments being either timed
continuous runs, or interval based tests [34–37]. Recently, there has been a transition towards the Yo-Yo
Intermittent and 30:15 Intermittent Recovery tests, as the recovery periods dispersed within the tests
are more sport specific. A version of the Yo-Yo test, the Yo-Yo IR2, has been shown to have a strong
relationship with high-speed running and match performance (measured by possessions) during an
AF game [8].
3.1.2. Strength and Power Assessments
In many sporting codes, the ability of an athlete to jump higher than their opponent may put
them at a distinct competitive advantage. As such, the vertical jump (VJ) test is commonly included as
a TID assessment, as a measure of explosive anaerobic power of the lower limbs [38–40]. To assess an
athlete’s VJ capability, there are typically two different tests performed, a stationary countermovement
jump and a dynamic countermovement jump. In both instances, the aim of the test is for the athlete to
attain maximum vertical displacement. The dynamic vertical jump is included in the testing barrage
of many sports, and is considered a more reflective test for power assessment in team sports. However,
while the VJ is a good measure of anaerobic power, it does not often relate to success in Australian
Football [11].
The peak force generated during the isometric mid-thigh pull (IMTP) strength test has also been
associated with VJ. The peak force was significantly related to countermovement and squat jump
performance in junior male and female surfers [41]. The IMTP has been used to assess collegiate
level American Football players and wrestlers, and was found to be an effectual and fast technique
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of measuring isometric strength [42,43]. When tested in female Olympic weightlifters, a near perfect
relationship between peak force during the IMTP and VJ peak power was seen [44]. Similar results
were seen in former colligate level male weightlifters, as there was a strong correlation between
isometric peak force and VJ performance [45]. The IMTP can also be used to monitor athletes, such as
weightlifters, as it delivers information of strength and explosiveness [46]; key areas in many sports
including AF.
3.1.3. Acceleration and Maximal Linear Sprinting Speed
To assess an athlete’s sprint capacity, maximum acceleration, and speed, and the ability to perform
repeated high-speed efforts are commonly used in talent pathways [47,48]. Often, acceleration and
maximum speed are assessed concurrently, with timing gates used to assess an athlete’s linear speed
often over 20–60 m [29,40,49]. In Australian Football (AF), the 20-m sprint has been shown to be
predictive of selection into underage representative and professional senior squads [27], and AFL
success [11]. Such an assessment is a good indicator of acceleration [27,50] and often provides important
performance information for recruiters in power-based sports, such as American football [51].
3.1.4. Muscle Fibre Composition
The structure and composition of skeletal muscle fibres has the potential to be used as a predictive
measure for athletic performance. For example, slow-twitch fibres (type I) are associated with
endurance events, while fast-twitch fibres (type II) are linked to short, explosive events. Type I
fibres have a higher aerobic capacity and myoglobin stores, allowing for greater blood flow and
improved oxygen delivery to the muscle [52]. In contrast, type II fibres breakdown ATP rapidly,
resulting in a fast muscle shortening cycle, and the production of more force [53,54]. Fast twitch fibres
have an abundance of glycolytic enzymes, allowing for a large anaerobic capacity [55]. As a result,
type II fibres are more fatigable than type I fibres.
Another method for muscle fibre assessment involves the measurement of muscle carnosine,
a muscle metabolite that cannot be easily influenced by environment, training, or diet [56,57].
Interestingly, fast-twitch fibres can have twice the amount of muscle carnosine than slow-twitch [57].
In athletes, levels of muscle carnosine are approximately 30% higher in sprinters and short-event
athletes, and approximately 20% lower in endurance event athletes, compared to the control
group [57]. The relative amounts of alpha-actin-3 and alpha-actin-2 can also influence muscle fibre
composition [58]. Alpha-actin-3 (fast-twitch) and alpha-actin-2 (slow-twitch) have the ability to
influence fibre characteristics in individual muscle [58]. The alpha-actin genotype can affect fibre-type
arrangement, metabolic profile, and contractile properties [58].
3.2. Measurements of Skill Performance
The sport specific assessment of skill is an essential and commonly examined component of
the TID process [14,39,40,59]. For example, in table tennis, eye-hand coordination is the first skill
assessment in the TID process [60]. Similarly, there have also been strong associations between
motor coordination and status level in female volleyball players, a sport where motor coordination
is an indicator of an athlete’s potential [61]. However, the assessment of skill is often a subjective
evaluation and therefore has an area of biased opinion [62]. Frequently, skill assessment is rated on
skill-specific criteria and is graded on a Likert scale, but due to the subjectivity of the observers making
the assessment, the reliability can be questionable. It must also be stated that some sport-specific skills,
such as tackling in rugby league, are more difficult to assess reliably, compared to other skills [62].
3.3. Measurements of Match Performance
Match performance is a measurement of contributions to a game and is reported as game day
statistics. Individually, methods of determining player achievement can be completed subjectively via
umpire or coach votes, or objectively using match-based statistics [12]. Using match statistics, such
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as handballs and kicks, an objective measurement of match performance can be calculated for AF
players [11,50]. Match statistics are accumulated in AF by a commercial analytics company (Champion
Data, South Bank, Australia) with reports of 99% accuracy [63] and have been previously used in
other studies involving AF [8,64]. Direct game involvement (DGI) can be used as a sum of handball,
kick, mark, and tackle statistics is a game of AF, and DGI per minute (DGI/min) can be used as a
measurement of game impact [12].
Often, talent identification and pre-season testing is used as an indicator of potential match
performance and fitness. Aerobic time trials, which are often apart of such testing batteries and
pre-season fitness measures, have previously been associated with improved match performance in
sub-elite AF players [12]. In lower body power assessments, the vertical jump does not correlate with
success in AF [11]; however, the 20-m sprint shows moderate positive correlations [11,27]. Coaches and
high performance managers may desire a more accurate and efficient method of gauging physical
capacities during testing and pre-season training, which opens the opportunity for the investigation of
genetic profiles in certain sports.
4. Contribution of Genetic Variation to Athlete Strength, Power, and Endurance
The question is often posed, what makes an athlete? External influences such as early-life
exposure, social-economic status, and training history influence an individual’s ability to succeed in
sport. However, a player’s genetics may play an important role in determining sporting achievement,
as athleticism, like many other individual characteristics, is, at least, a partially inherited trait [1].
There are allelic variants within genes that have been identified as predisposing individuals to elite
endurance or elite power. The ACE and ACTN3 genes both have one homozygous variation that
predisposes individuals to power and another to endurance [18,65–69]. While the ADRB 1/2/3 and
PPARGC1A genes that influence endurance performance, one homozygous variation positively impacts
endurance performance and the other negatively impacts endurance performance [21–23,70–74].
Besides athletic traits—such as endurance, strength, and power—other traits such as skill acquisition
and development affect a person’s success in sport, especially team sports such as AF. There is
evidence from several genes (BDNF, DRD2, COMT) that show they impact motor coordination and/or
development [24,25,75].
4.1. The Role of ACE
The human ACE gene is an important part of the renin-angiotensin-aldosterone system
(RAS). This system is involved in circulatory homeostasis [76], skeletal muscle growth [77] and
cardiovascular function [78]. The ACE gene is located on chromosome 17 and has an insertion/deletion
polymorphism of 287 base pairs, resulting from an Alu repeat sequence, shown to insert within intron
16 [79]. This produces three well-documented ACE insertion/deletion genotypes; II homozygote,
DD homozygote, and ID heterozygote. Previous studies have shown the ACE polymorphism
to be correlated with cardiovascular disease risk and complications [80], proliferative diabetic
retinopathy [81], Alzheimer’s disease [82], and acute macular degeneration [83]. The frequency
of the ACE I/D genotype shows variation amongst ethnic populations [84,85], and also correlates with
athletic traits in a number of elite sporting codes. However, in simple movements such as a squat jump
or countermovement jump, neither homozygous ACE genotype (DD or II) has shown correlation to
performance [86].
The ACE insertion allele indicates the presence of an Alu repeat sequence within the gene.
The homozygous insertion allele (I) is associated with lower plasma levels of ACE enzyme, and
has been linked to the onset and progression of Alzheimer’s disease [87]. In a sporting context,
the frequency of I alleles appears to increase with race distance in studies of elite Caucasian
runners [18] and swimmers [68]. Therefore, the insertion ACE allele appears to be an advantageous
genotype for endurance sports. Athletes with this allele tend to demonstrate an increased aerobic
capacity [79,88] and better performance in a range of endurance sports [89]. However, a smaller
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number of contradictory studies have also demonstrated no relationship between the I allele and
endurance athletes [90] or maximal oxygen consumption (VO2max) [89], a measure of aerobic capacity.
Possible reasons for these contradictions include diverse group of athletes with a small percentage
of endurance athletes, the examination of elite and sub-elite athletes, and environmental factors [88].
Orysiak, Zmijewski, Klusiewicz, Kaliszewski, Malczewska-Lenczowska, Gajewski, and Pokrywka [88]
even suggested that the ACE gene has a minor role in endurance performance, implying that the ACE
polymorphism has a greater relationship with strength and power, and the deletion allele.
The deletion allele of the ACE gene has commonly been studied in association with sporting
codes dependent on strength and/or power. This particular allele is associated with circulating
plasma levels of ACE, with a DD genotype resulting in significantly higher levels of ACE compared
to a II genotype [91]. Elevated levels of ACE can contribute to ischaemic heart disease and other
complications arising from increased activation of the angiotensin system [92]. However, the deletion
genotype (DD) has also been associated with increased musculoskeletal fitness [93] in strength-related
individual sports. For example, European Caucasian elite short distance swimmers [18,69], and track
and field [67] athletes, were found to have increased D alleles compared to controls. In contrast, a
population of Lithuanian soccer players [78] and South East Asian rugby players [79] were found
to have significantly lower proportions of the D allele. This is surprising, considering that both
sporting codes have elements of strength and power, suggesting ethnicity and additional factors
may also be at play. Similar studies have also revealed no correlation between ACE I/D alleles and
individual [67,94,95] and team [95] sports (Table 1). More recently, a multinational study investigating
the ACE I/D alleles in Caucasian endurance athletes failed to identify a correlation between genotype
and performance time [96].
4.2. The Role of ACTN3
A member of the actin family, actini-alpha-3 (ACTN3) is a protein highly expressed in muscle
tissue, which functions to crosslink actin filaments in fast-twitch (type II) skeletal muscle fibres [97].
Expression in glycolytic skeletal muscle allows this protein to contribute towards powerful muscle by
coordinating fast-twitch muscle contractions [97]. The ACTN3 gene, coding for this protein, has been
thrust into the forefront of genetic studies following the identification of a nonsense polymorphism at
position 577 (rs1815739), which significantly affects ACTN3 protein levels due to a premature stop
codon within the ACTN3 gene [97]. The most common nucleotide at position 577 is a cytosine (C allele)
encoding an arginine amino acid (arginine = R), with the alternative T allele encoding a stop codon
(stop = X). Therefore, within the literature, the CC genotype is referred to as RR, whereas the TT
genotype is often called XX (referred to herein as R577X). Interestingly, over a billion people worldwide
are believed to carry the homozygous absent XX genotype and be deficient in this protein [97,98].
Studies examining the effect of an ACTN3 knock out in mice show alpha-actin 2 levels increase,
resulting in a transition of fibre type towards fatigue resistance, as a compensatory mechanism for the
absence of functional ACTN3 protein [58]. Similar to in vivo studies, athletes with an XX genotype
show an increased tendency to perform endurance sports, as shown by an increased frequency of this
particular allele (Table 1).
There is currently a strong association between the homozygous R allele of ACTN3 and
strength/power athletic phenotypes [16,97,99–101]. Furthermore, there has also been evidence that a
higher proportion of slow-twitch muscle fibres are related to the X allele genotype and elite endurance
status [17,98,102]. In team sports, a cohort of Brazilian soccer players with the RR genotype performed
significantly better at short distance sprints and jump tests compared to athletes with the RX and XX
genotypes [103].
4.3. Additional Candidate Genes Implicated in Strength and Power
A number of additional genes have been identified as being strong indicators of athletic status
(see Table 1). The majority of these genes encode proteins that are associated with muscle tissue or
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cardiovascular function [104]. The angiotensin II receptor type 2 (AGTR2) gene, associated with the
RAS system, has been implicated in power sports due to its association with fast-twitch muscle fibre
composition [77]. A polymorphism in this gene (rs699) has been found to occur more frequently in
females (A allele) than males (C allele). Interestingly, the A allele correlates with selection to strength
and power sports, when compared to control or C allele groups [77].
Similarly, a number of polymorphisms relating to genes responsible for oxygen delivery have been
identified as predictors for strength and power performance. The two variations in the endothelial PAS
domain protein 1 (EPAS1) gene, the hypoxia inducible factor 1 A (HIF1A) and the nitric oxide synthase
3 (NOS3) genes, have shown an association with sprint and power sports, when compared to control
groups [105–107]. Within a group of Polish and Russian athletes, two homozygous genotypes of the
EPAS1 variants were found to be under-represented in sprint and power athletes [107]. While the CC
genotype of the HIF1A gene is more frequent in wrestlers and weightlifters [106] and the T allele of the
NOS3 gene has been shown to be associated with, therefore beneficial to, power sports [105].
4.4. Additional Candidate Genes Implicated in Endurance and Aerobic Capacity
Despite a heavy focus on the role of the ACE insertion/deletion polymorphism, there have been
a number of recent genes implicated in aerobic/endurance performance (see Table 1). The ADRB
1/2/3 genes are an example of this, and function to encode G-coupled receptors in cardiac and adipose
tissue, regulating cardiac function and metabolism [73]. Specifically, a single base variation in ADRB1
(rs1801253) can drastically increase VO2max, exercise time and endurance (C allele), or cause a decrease
in VO2max (G allele) [74]. Similarly, the G allele in ADRB2 (rs1042713) is strongly correlated with
increased BMI and decreased VO2max [72]. Finally, a study on Spanish athletes showed a rare C allele
in ADRB3 (rs4994) strongly correlated with elite endurance performance [23], making this an ideal
predictive marker.
The PPARGC1A gene plays an important role in metabolism. PPARGC1A functions as an activator
of oxidative phosphorylation genes, ultimately controlling glucose and lipid metabolism [70,71]. Further,
it has been linked to skeletal muscle fibre formation, and the determination of fibre type [71]. A single
base variation (rs8192678) in different populations can correlate to different outcomes. For example,
studies show that European men homozygous for the A allele (AA genotype) have an extremely strong
correlation with higher VO2max and endurance. In contrast, Chinese men that are homozygous for the
G allele (GG genotype) show a strong association with higher VO2max and endurance [21,22].
Table 1. Previous studies assessing the role of genes in determining athletic performance
Gene Sport/Discipline Outcome of Study Reference
ACE
Basketball Higher proportion of I allele frequency than D allele amongst athletes [90]
Cross country skiing No significance reported [67]
Cycling
Significantly higher I allele frequency among long-distance Spanish,
male, elite cyclists [65]
Higher proportion of D allele frequency than I allele amongst athletes [90]
Endurance sports Increased frequency of DD genotype in endurance athletes comparedto power athletes [84]
Handball Significantly higher I allele frequency among Spanish, male, elitehandball players (national team) [65]
Power sports Decreased frequency of DD genotype in elite Korean power athletescompared to a control group [85]
Running (long distance)
Increasing I allele frequency with increasing race distance in elite
British and Spanish runners [18,65]
No significance reported [96]
Running (short distance)
Increased DD genotype and D allele frequency in sprinters [18,19]
No significance reported [94,95]
Rhythmic gymnastics D allele was more frequent in elite level gymnastics compared tosub-elite athletes and controls [108]
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Table 1. Cont.
Gene Sport/Discipline Outcome of Study Reference
Soccer
Significantly lower DD, greater ID genotype in Lithuanian
professional soccer players [78]
Significantly higher frequency of ID genotype and lower frequency of
II genotype in soccer players compared to endurance runners [109]
Swimming
Significant association between the DD genotype and elite, short
distance swimmers [69,110]
Significantly greater I allele in middle distance Russian swimmers.
Increasing I allele frequency with increasing race distance in elite long
distance swimmers
[67,68]
No significance reported [95]
Volleyball
Higher proportion of I allele frequency than D allele amongst athletes [90]
No significance reported [95]
Weightlifting Equal distribution of D and I alleles amongst athletes [90]
ACTN3
Endurance sports
No significance reported [96,111]
Higher frequency of the XX genotype in the endurance athletes [17,112]
Power sports Significantly lower frequencies of the XX genotype, and higherfrequency of the RR genotype, compared to the control groups
[16,17,100,
113,114]
Soccer Significantly higher proportion of the RR genotype than the controlgroup [115]
Swimming No significance reported [95,116]
Running (short distance)
No significance reported [94,95,115]
No significantly less XX genotype in sprinters. Increased frequency of
RR and R allele in elite sprinters compared to control group [16,21,97,112]
Volleyball No significance reported [95,117]
ADRB1 Endurance sports C allele is associated with increased VO2max, exercise time, andexhaustion. G allele is associated with decreased VO2max
[23,74,118]
PPARG-C1A
Endurance sports Endurance athletes have a higher proportion of GG genotype, and alower frequency of A allele [21,22]
Sprinting GG genotype is associated with increased endurance ability and AAgenotype may be associated with impaired aerobic capacity [21,22]
5. Genetic Links to Ability and Skill in Sport
5.1. BDNF Polymorphism and Motor Skill Acquisition
Brain-derived neurotropic factor (BDNF) protein has an effect on vascular and neuronal growth,
as well as brain, spinal cord, skeletal muscle development and regeneration [119–123]. Structural and
functional changes can occur due to different SNPs in the BDNF gene [124]. The binding and
internalisation of the BDNF protein can affect axonal path finding [125], differentiation, neuronal
survival [126], formation and conservation of late-phase potentiation [127], hippocampus neuronal
death defence [128], and dendritic trafficking regulation [129].
The BDNF Val66Met polymorphism (rs6265), found on codon 66 [75], is known to impact on the
ability of humans and mice to develop motor skills [24]. Fritsch, Reis, Martinowich, Schambra, Ji,
Cohen, and Lu [24] found that BDNF levels are elevated during motor skill training, when participants
completed a sequential visual isometric pinch task. This could be due to the secretion of BDNF needed
to increase synaptic plasticity in the motor cortex of the brain [24]. Corticospinal output of BDNF
encoded by the AA genotype increased after motor training, while AG and GG genotypes showed
reverse effects [130]. This suggests that the effect of the polymorphism does not occur in the basal state,
but due to increased neural activity as a behavioural response [130]. The Val66Met polymorphism
is also related with short term reduced motor learning and changed motor cortex plasticity [75].
For example, AG carriers exhibit poorer motor learning in simple motor tasks, such as a serial reaction
time task, compared to AA genotypes [75].
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5.2. Dopamine Receptors and Procedural Learning of Complex Skills
Dopamine polymorphisms are associated with many neurological and mental disorders that are
characterised by changes in cognitive and emotional processes [25]. Huertas, Buhler, Echeverry-Alzate,
Gimenez, and Lopez-Moreno [25] found a connection between a SNP in the DRD2 gene (rs1800497),
situated in exon 7, which affects mirror drawing, a visual-motor task that requires procedural learning.
From this study, C allele and T allele carriers showed a similar ability at the commencement of the task,
however C allele carriers learnt more as the task continued [25]. The results were unexpected as C allele
carriers are related to low striatal DRD2 availability [131] and high DRD2 binding potential within
the thalamus and cortex [132]. However, there are two possible explanations for this. The low striatal
density, linked with the C allele genotype, may cause a higher affinity to compensate by an optimisation
of G-protein-coupled signalling, leading to more effective learning [25]. Another explanation is that in
the study, both CC and TT genotypes showed an increased heart rate during the task; stress has been
showed to increase striatal dopamine release [133]. The stress produced during the task may have
caused compensation in the low striatal density, providing optimal learning circumstances [25].
Catechol-O-methyltransferase (COMT) is an enzyme that promotes the breakdown of dopamine,
a process essential for cognitive function [134]. A COMT polymorphism at position 158 (Val158Met),
resulting in either an A or G allele (rs4680), has been associated with motor control, and linked with the
expression of DRD2 [135]. Individuals homozygous for the A allele (Met) have reduced COMT enzyme
activity, resulting in increased dopamine activity, compared with G carriers (Val) [135]. Furthermore,
pairing both homozygous AA COMT and CC DRD2 genotypes can allow for higher rates of motor
learning [135]. While these genes have been linked to motor learning and coordination, it has not been
investigated whether they affect sport-specific skill acquisition.
6. Ethical Considerations
It is important to consider the ethical issues that could arise from the genetic testing of potential
athletes. From a public health perspective, medical genotyping is seen as presumptuous, divisive,
and discriminatory [136]. Therefore, in a sporting context, the suggestion that athletes should be left
out of elite training pathways based solely on their genome would likely be considered by many as
unethical [137]. However, including a junior athlete in a development program based on their genotype
is a more inclusive measure of TID and could allow for late-developers to receive appropriate coaching
while they mature [138]. This would allow for fair selection once all the athletes have reached the same
maturity as the early-developers would not have been put at an advantage based on anthropometric
and physical testing from adolescent years. The genetic screening should not be used as a measure of
complete athletic potential, but as a predictive tool in athlete potential [138]. Other ethical concerns
that arise from the notion of genetic testing for TID purposes are the restricting of participation options,
early specialisation risks, and potentially missing out on other opportunities that could provide
enjoyment [139]. However, what genetic testing can be used for is guiding interventions that could
reduce injury and improve an individual’s health [137,140].
7. Conclusions
Current TID processes have been utilised for years with basic practises having been expanded on
to include sport-specific tasks, involving skill. With modern technology, there is potential to examine
an athlete’s genetic makeup and investigate whether a particular genotype can contribute to athletic
performance. The ACE and ACTN3 genes have shown strong potential to predict athletic prowess
in both endurance or power and strength-based sports, while numerous other genes have shown
associations with one or the other. Even more exciting is the possibility to prophesise motor control
and development in relation to skill acquisition and performance in sport. Variants in the BDNF, DRD2,
and COMT genes are possible candidates for future research aiming to investigate such possibilities in
different sports. However, it must be stressed that the identification of athletic talent is unlikely to be
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the result of a small number of genetic variants, rather a complex combination of a large number and
pattern of expressed genes, as well as a number of environmental conditions.
The ability to develop training programs custom made for athletes based on their known areas of
need has very plausible implications. Most coaches have used the phrase “practise makes perfect” and
many coaches and sport scientists will say that training time is limited for a multitude of reasons.
Research into this area can be used to determine if a particular genotype allows for athletes to
better perform and react to certain training stimuli, allowing for a more well-rounded view on training
specification. Further research conducted should therefore investigate how a player’s genotype may
contribute to training outcomes and adaptations. A major draw to prospective athletes to a given
sporting club, or institute, is their ability to cater and individualise training programs to the individual
athlete. Introducing genetic testing to these programs will allow athlete specific training regimes to
improve athletic, skill, and match performance.
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